Advertisement

Topics

Archemix Corp. Company Profile

13:55 EDT 21st September 2017 | BioPortfolio

Archemix is the biopharmaceutical company leading the development of aptamers as a new class of directed therapeutics for the prevention and treatment of chronic and acute disease. Archemix believes the unique properties of aptamers hold extraordinary potential in the fast-breaking world of drug discovery and development. Because of their unequaled specificity for their molecular targets, aptamers provide a promising alternative to conventional therapeutic approaches. Aptamers can be used in a wide range of disease areas, including many of those currently addressed by protein-based therapeutics. Aptamers demonstrate little to no immunogenicity or toxicity, and can be produced quickly and economically.

Location

300 Third Street
Cambridge
Massachusetts
02142
United States of America

Contact

Phone: 617-621-7700
Fax: 617-621-9300
Email: info@archemix.com


News Articles [47 Associated News Articles listed on BioPortfolio]

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

GTX Corp Receives Military Contract

LOS ANGELES, CALIFORNIA , Sept. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive ...

GTX Corp Partners with ORBCOMM to Enable GPS SmartSoles on the Verizon Network

LOS ANGELES, CALIFORNIA , Sept. 12, 2017 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive te...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, tod...

pSivida Corp. Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track

 EU and US Calendar 2017 Registration Filing Milestones for Durasert™ for Posterior Segment Uveitis Remain on Schedule Conference Call and Webcast Today, May 4th, at 4:30 p.m. ET WATERTOWN, M...

Cannabco Pharmaceutical Corp. Secures $24 Million in Capital for Build Out of Its Cannabis Cultivation Facilities

TORONTO, May 04, 2017 (GLOBE NEWSWIRE) -- Cannabco Pharmaceutical Corp. ("Cannabco" or the "Company") is pleased to announce that the company has entered in to a binding interim agreement for fin...

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will presen...

Orkla Food Ingredients signs licence agreement with Renaissance BioScience Corp. for Acrylamide-Reducing Yeast Technology

OSLO, Norway and VANCOUVER, British Columbia, May 23, 2017 (GLOBE NEWSWIRE) -- Orkla Food Ingredients, a business area of Orkla ASA (OSE:ORK) has signed a licence agreement with Renaissance BioSc...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [39 Associated Companies listed on BioPortfolio]

Archemix Corp.

Archemix is the biopharmaceutical company leading the development of aptamers as a new class of directed therapeutics for the prevention and treatment of chronic and acute disease. Archemix believes t...

Archemix

Archemix is a drug discovery and development company founded by experts in molecular biology and drug discovery, and backed by experienced biotech investors. Using proprietary technologies, we create ...

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

Precision Engineered Products LLC

More Information about "Archemix Corp." on BioPortfolio

We have published hundreds of Archemix Corp. news stories on BioPortfolio along with dozens of Archemix Corp. Clinical Trials and PubMed Articles about Archemix Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Archemix Corp. Companies in our database. You can also find out about relevant Archemix Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record